Beijing’s Bohui Innovation Co. commercializes PCR-based diagnostic system for rapid detection of influenza A and B-type DNA

With a probe taken from pharyngeal swabs, either virus DNAS can be detected qualitatively. The product was developed by the company’s Guangzhou subsidiary Bohui Biotechnology Development Ltd.

China Bio news release, October 25, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny